đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
This study compares the safety and immunogenicity profile of combined hepat...
Status
Completed
Location
03, Novartis Investigational Site
Start Date
2011-10
Trial ID
NCT01453348
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The purpose of this study is to determine the effects of an HIV vaccine (Re...
Status
Completed
Location
Univ. of Iowa Healthcare, Div. of Infectious Diseases
Start Date
TBD
Trial ID
NCT00000943
This is a follow-up of Study A3L11 (NCT00404651). Immunogenicity * To des...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00654901
Primary :1.To demonstrate a sufficient immune response of rMenB+OMV NZ, whe...
Status
Completed
Location
Novartis Investigational Site Nr. 59
Start Date
2008-08
Trial ID
NCT00721396
The primary objectives of this study are to evaluate the immunogenicity and...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-30
Trial ID
NCT01553279
Treatments Being Tested
This study will look at your body's response to the new immunizations. We w...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2007-07-10
Trial ID
NCT00505063